What is Foscarbidopa Foslevodopa?
Foscarbidopa foslevodopa is a combination drug developed to treat Parkinson's disease [1]. It consists of foscarbidopa and foslevodopa, which are prodrugs of carbidopa and levodopa, respectively [1]. Levodopa is a precursor to dopamine, a neurotransmitter that is deficient in Parkinson's patients, while carbidopa helps prevent levodopa from being broken down before it reaches the brain [1].
How Does Foscarbidopa Foslevodopa Work?
Once administered, foscarbidopa and foslevodopa are converted in the body to carbidopa and levodopa [1]. The levodopa then enters the brain and is converted to dopamine, helping to alleviate Parkinson's symptoms like tremors, rigidity, and slowness of movement [1]. The carbidopa inhibits the breakdown of levodopa in the periphery, increasing the amount of levodopa available to reach the brain [1].
How Does Foscarbidopa Foslevodopa Compare to Rytary?
Both foscarbidopa foslevodopa and Rytary (a brand name for carbidopa-levodopa extended-release) are used to treat Parkinson's disease [1, 2]. Rytary also uses carbidopa and levodopa but is formulated for extended release, aiming to provide more consistent levodopa levels [2]. Foscarbidopa foslevodopa is designed as an oral formulation delivered through a gel [1]. Clinical studies have compared the efficacy and safety profiles of these treatments.
What is the Development Status of Foscarbidopa Foslevodopa?
Foscarbidopa foslevodopa has undergone clinical trials, including Phase 3 studies, to evaluate its effectiveness and safety for Parkinson's disease symptoms [1].
When Might Foscarbidopa Foslevodopa Become Available?
Regulatory reviews and potential approvals will determine the availability of foscarbidopa foslevodopa to patients [1].
What Are the Potential Side Effects of Foscarbidopa Foslevodopa?
As with most Parkinson's medications, potential side effects of foscarbidopa foslevodopa include dyskinesias (involuntary movements), nausea, dizziness, and somnolence [1]. The specific side effect profile is evaluated during clinical trials.
Are There Any Patents for Foscarbidopa Foslevodopa?
Information regarding patents for foscarbidopa foslevodopa can be found on specialized patent tracking websites [1].
Sources:
[1] https://drugpatentwatch.com/drug/foscarbidopa-foslevodopa
[2] https://drugpatentwatch.com/drug/rytarry